KOHESIO · Q7510302 · BE

PEPVAC CERg

Research project aimed at setting up an innovative platform for pre-clinical evaluation of new vaccine candidates and risk factors based on the strengthening of a university-approved research centre partnership.

EU budget
€597k
Total project cost
€1.5M
Period
2023-01-01 → 2025-12-31
Thematic objective
PO01PO01

Co-funding: the EU contributes €597k toward a total project cost of €1.5M — a co-funding rate of 40%, with the remainder covered by national, regional or private sources.

Kohesio is the European Commission's open-data platform for projects co-financed by the European Regional Development Fund, the European Social Fund Plus, the Cohesion Fund and the Just Transition Fund. It draws on lists of beneficiaries published by national managing authorities and harmonises them into a single EU-wide view.

Full project record on Kohesio — partners, deliverables, location map, related funding decisions.

Open on kohesio.ec.europa.eu →

Frequently asked questions

What is the EU budget for this project?
The EU contributes €597k toward a total project cost of €1.5M, a co-funding rate of 40%.
Which fund or thematic objective does it belong to?
This project falls under EU Cohesion Policy thematic objective PO01 — PO01 — financed through the European Structural and Investment Funds.
Which country is the project located in?
The project is located in BE.
What is the project period?
The project runs from 2023-01-01 to 2025-12-31.
Where can I find the full project record?
The complete project record — beneficiary, location and related funding decisions — is published on Kohesio, the European Commission's open-data platform, under reference Q7510302.